On Friday, researchers at the Technical University of Denmark demonstrated that a quantum computer can enhance the accuracy of generative artificial intelligence models used in drug discovery. This innovative approach was made possible by utilizing spare resources from other projects and involves a collaboration with British startup Orca Computing.
The team ran their generative AI model for predicting proteins alongside a compact quantum computer, significantly improving the speed and efficiency of AI processes. This hybrid technique has been instrumental in generating novel peptides, which are essential for vaccine development as they bind to specific proteins in the body.
Advancements in AI and Quantum Computing
The research team utilized a quantum computer to enhance their AI workflows, enabling them to produce peptides that show a higher success rate in binding to targeted proteins. According to DTU professor Timothy Patrick Jenkins, the results indicated that their model outperformed classical counterparts, especially in cases where training data was limited.
“We needed to really prove it to convince skeptics that our predictions connect to the real world,” Jenkins told WIRED. The research highlights the potential of quantum computing in making significant strides in personalized immunotherapies and vaccines.
Challenges in Drug Development
Despite the promising results, quantum computing remains an emerging field fraught with challenges. Jonathan Funk, a PhD student at DTU, noted that current quantum machines cannot yet handle the complexity of full-scale AI models, limiting their application in drug discovery.
- Quantum computers are still small and not capable of running advanced AI models.
- Most biological models require extensive data, but a lack of diverse genetic information complicates peptide development.
- Research has predominantly focused on Western populations, impacting the efficacy of drugs in understudied groups.
Jenkins and his team are exploring ways to integrate quantum computing further into their workflows, aiming to enhance their generative AI methods to design synthetic antidotes for conditions like snakebite venom.
Future Prospects for Quantum Computing in Medicine
The study represents a significant step towards demonstrating a near-term commercial application for quantum technology in healthcare. Richard Murray, CEO of Orca Computing, emphasized the importance of showcasing practical applications of quantum computing, which have often been viewed as distant possibilities.
As research continues, the DTU team is optimistic about applying this workflow to more advanced models and larger proteins. “We needed this as an easy way to validate that now we actually have a shot at moving the needle substantially,” Jenkins stated.
🤖 This article was rewritten by Feed and Figures' editorial AI from a report originally published by Wired. Facts and quotes are preserved from the original; the rewrite focuses on clarity and structure. For the unedited original, see the source link below.
